Discover
SCNI
Scinai Immunotherapeutics Ltd.
0.27
2 x 0.19
2 x 0.33
bid
ask
+
0.02
7.68%
2 @ 04:00 PM
0.26 -0.01 (3.31%)
| Ytd | -61.80% | |
| 1y | -89.08% |
0.25
day range
0.27
0.24
52 week range
3.48
| Open | 0.25 | Prev Close | 0.25 | Low | 0.25 | High | 0.27 | Mkt Cap | 1.41M |
| Vol | 86.95K | Avg Vol | 3.55M | EPS | 1.75 | P/E | 0.16 | Forward P/E | N/A |
| Beta | 2.46 | Short Ratio | 0.09 | Inst. Own | 2.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.46 | 200-d Avg | 0.85 | 1yr Est | 700.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-22 | 2024-09 | 0 | 8.4 | N/A | N/A |
| 2024-08-15 | 2024-06 | 0 | -3.57 | N/A | N/A |
| 2024-07-02 | 2024-03 | 0 | -4 | N/A | N/A |
| 2024-05-15 | 2023-12 | 0 | -240 | N/A | N/A |
| 2023-10-31 | 2023-09 | 0 | -6.6 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Rhumbline Advisers | 1.65K | 5.54K | 0.19% |
| 2024-09-29 | Morgan Stanley | 255.00 | 854.00 | 0.03% |
| 2024-09-29 | Aspire Private Capital, LLC | 32.00 | 107.00 | 0.00% |
| 2024-09-29 | Credit Agricole S.A. | 42.00 | 140.00 | 0.00% |
| 2024-09-29 | UBS Group AG | 30.00 | 100.00 | 0.00% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | SPDR Portfolio Developed World ex-US ETF | 2.00 | 6.00 | 0.00% |
Split
| Split | Date |
|---|---|
| 1 : 10 | 2024-05-21 |